XML 111 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Operating activities:      
Net income $ 151,164 $ 48,983 $ 67,826
Non-cash elements included in net income:      
Depreciation, depletion and amortization 47,348 60,235 63,061
Net gain on sale of investments (611) (588) (4,070)
Loss on impairment of investments 140 739 3,018
Loss (gain) on disposition of properties, plants, equipment and mineral interests   80 (6,234)
Provision for reclamation and closure costs 7,004 196,262 5,172
Deferred income taxes 76,944 (141,707) (7,100)
Stock compensation 2,073 3,446 2,746
Preferred shares issued for debt-related fees     4,262
Amortization of loan origination fees 598 621 3,993
Amortization of intangible asset   1,380 1,388
Gain on termination of employee benefit plan     (8,950)
(Gain) loss on derivative contracts (53,545) 20,795 2,139
Other non-cash items 1,209 (495) (55)
Change in assets and liabilities:      
Accounts receivable 16,531 (9,404) (18,117)
Inventories (7,064) 2,335 (135)
Other current and noncurrent assets 2,164 3,279 (1,526)
Accounts payable and accrued liabilities 1,466 10,896 (3,663)
Accrued payroll and related benefits 2,090 (3,376) 6,015
Accrued taxes (5,688) 9,802 4,866
Accrued reclamation and closure costs (172,855) (8,666) 1,540
Other non-current liabilities 923 3,192 2,989
Net cash provided by operating activities 69,891 197,809 119,165
Investing activities:      
Additions to properties, plants, equipment and mineral interests (87,546) (67,414) (27,704)
Proceeds from sale of investments 1,366 1,138 4,091
Proceeds from disposition of properties, plants and equipment 113 29 8,023
Redemptions of restricted cash and investment balances 9,448 1,459 3,487
Increases in restricted cash and investment balances (3,200)    
Net cash used by investing activities (79,819) (64,788) (12,103)
Financing activities:      
Proceeds from exercise of warrants and stock options 5,786 53,093  
Proceeds from issuance of common stock and warrants, net of related expense     128,334
Dividends paid to common shareholders (5,592)    
Dividend paid to preferred shareholders (3,822) (4,513)  
Loan origination fees paid (180) (200) (1,467)
Payments on interest rate swap     (3,013)
Treasury share purchase (469) (693)  
Repayments of debt and capital leases (2,938) (1,780) (162,708)
Net cash provided by (used in) financing activities (7,215) 45,907 (38,854)
Net increase (decrease) in cash and cash equivalents (17,143) 178,928 68,208
Cash and cash equivalents at beginning of year 283,606 104,678 36,470
Cash and cash equivalents at end of year 266,463 283,606 104,678
Cash paid during year for:      
Interest, net of amount capitalized 1,683 584 6,683
Income tax payments 17,874 11,075 1,025
Significant non-cash investing and financing activities:      
Stock issued for acquisition of assets 33,831    
Capital leases acquired 6,935 3,212 5,682
Equity securities received from dispositions of assets     299
Accounts payable change relating to capital additions 8,687 3,488 (4,190)
Preferred stock dividends paid in common stock   $ 22,891